NeoGenomics, Inc. Accounts Receivable, Allowance for Credit Loss, Current
NeoGenomics, Inc. (NEO) had Accounts Receivable, Allowance for Credit Loss, Current of $11.06 million as of 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2016-11-07
- 2016-09-30: Accounts Receivable, Allowance for Credit Loss, Current $11.06M.
- 2016-06-30: Accounts Receivable, Allowance for Credit Loss, Current $9.20M.
- 2016-03-31: Accounts Receivable, Allowance for Credit Loss, Current $7.34M.
- 2015-12-31: Accounts Receivable, Allowance for Credit Loss, Current $4.76M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2016-09-30 | $11.06M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $9.20M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $7.34M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.76M 10-Q · filed 2016-11-07 |
| 2015-09-30 | $4.48M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $4.19M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $4.08M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $4.18M 10-K · filed 2016-04-18 |
| 2014-09-30 | $5.47M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $5.71M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $4.57M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.54M 10-Q · filed 2014-11-04 |
| 2013-09-30 | $4.36M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $4.15M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $3.62M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $3.00M 10-K · filed 2014-02-24 |
| 2012-09-30 | $2.55M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $2.47M 10-Q/A · filed 2012-08-15 |
| 2012-03-31 | $2.29M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $2.15M 10-K · filed 2013-02-21 |
| 2011-09-30 | $2.05M 10-Q · filed 2011-10-25 |
| 2011-06-30 | $1.84M 10-Q/A · filed 2011-08-01 |
| 2010-12-31 | $1.46M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |